Thalassemia Patients and Friends
Home
Help
Login
Register
Luspatercept vs. Sotatercept
Thalassemia Patients and Friends
Discussion Forums
Working Towards a Cure
Luspatercept vs. Sotatercept
« previous
next »
Print
Pages:
1
Go Down
Luspatercept vs. Sotatercept
3 Replies
6840 Views
CrazyPharm
44
Gender:
Luspatercept vs. Sotatercept
«
on:
December 22, 2014, 10:51:44 AM »
Can anyone highlight the differences between Sotatercept and Luspatercept. Apparently Acceleron and Celgene will most likely be moving forward with only one of these drugs? does anyone have some info. on this?
Also, their phase II trial in Thalassemia received funding from Novartis. Confused but how does Novartis tie into this? I know Dr. Piga has worked with them but aside from that...bluntly speaking: what's in it for them?
Logged
Andy Battaglia
8793
Gender:
Will thal rule you or will you rule thal?
Re: Luspatercept vs. Sotatercept
«
Reply #1 on:
December 22, 2014, 03:37:10 PM »
Contrary to popular perception, it is far more likely for a company like Novartis to buy a company for an already developing drug, than to develop one themselves. I would say Novartis has a potential future financial interest.
Logged
Andy
All we are saying is give thals a chance.
CrazyPharm
44
Gender:
Re: Luspatercept vs. Sotatercept
«
Reply #2 on:
December 22, 2014, 04:11:07 PM »
Thanks Andy, my thoughts exactly! Novartis seems to jump on Thalassemia drugs. On a different note: any idea when the Brand patent on Exjade expires?
Logged
ama
19
Re: Luspatercept vs. Sotatercept
«
Reply #3 on:
December 22, 2014, 08:13:14 PM »
Exjade Patent is supposed to expire on April 5, 2019.
Logged
Print
Pages:
1
Go Up
« previous
next »
SMF spam
blocked by CleanTalk